Recruiting Pulmonary Fibrosis Studies in Miami
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study. People can only take part if they show no improve...
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....
About Pulmonary Fibrosis Clinical Trials in Miami
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 2 pulmonary fibrosis clinical trials recruiting participants in Miami, FLORIDA. These studies are seeking a combined 528 participants. Research is being sponsored by Boehringer Ingelheim, Cumberland Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Miami — FAQ
Are there pulmonary fibrosis clinical trials in Miami?
Yes, there are 2 pulmonary fibrosis clinical trials currently recruiting in Miami, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov